381 related articles for article (PubMed ID: 33890634)
1. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gestational diabetes mellitus.
Alur V; Raju V; Vastrad B; Tengli A; Vastrad C; Kotturshetti S
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33890634
[TBL] [Abstract][Full Text] [Related]
2. Analysis of key genes and their functions in placental tissue of patients with gestational diabetes mellitus.
Wang Y; Yu H; Liu F; Song X
Reprod Biol Endocrinol; 2019 Nov; 17(1):104. PubMed ID: 31783860
[TBL] [Abstract][Full Text] [Related]
3. Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis.
Kolur V; Vastrad B; Vastrad C; Kotturshetti S; Tengli A
BMC Cardiovasc Disord; 2021 Jul; 21(1):329. PubMed ID: 34218797
[TBL] [Abstract][Full Text] [Related]
4. Identification of Key Pathways and Genes in Obesity Using Bioinformatics Analysis and Molecular Docking Studies.
Joshi H; Vastrad B; Joshi N; Vastrad C; Tengli A; Kotturshetti I
Front Endocrinol (Lausanne); 2021; 12():628907. PubMed ID: 34248836
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub-methylated differentially expressed genes in patients with gestational diabetes mellitus by multi-omic WGCNA basing epigenome-wide and transcriptome-wide profiling.
Chen M; Yan J; Han Q; Luo J; Zhang Q
J Cell Biochem; 2020 Jun; 121(5-6):3173-3184. PubMed ID: 31886571
[TBL] [Abstract][Full Text] [Related]
6. Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules.
Prashanth G; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
BMC Endocr Disord; 2021 Apr; 21(1):80. PubMed ID: 33902539
[TBL] [Abstract][Full Text] [Related]
7. Predicting of disease genes for gestational diabetes mellitus based on network and functional consistency.
Zhang Q; He M; Wang J; Liu S; Cheng H; Cheng Y
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():91-6. PubMed ID: 25666344
[TBL] [Abstract][Full Text] [Related]
8. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alternations of microRNAs and DNA methylation contribute to gestational diabetes mellitus.
Zhu W; Shen Y; Liu J; Fei X; Zhang Z; Li M; Chen X; Xu J; Zhu Q; Zhou W; Zhang M; Liu S; Du J
J Cell Mol Med; 2020 Dec; 24(23):13899-13912. PubMed ID: 33085184
[TBL] [Abstract][Full Text] [Related]
11. Identification of diagnostic biomarkers in patients with gestational diabetes mellitus based on transcriptome gene expression and methylation correlation analysis.
Li E; Luo T; Wang Y
Reprod Biol Endocrinol; 2019 Dec; 17(1):112. PubMed ID: 31881887
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis.
Pujar M; Vastrad B; Kavatagimath S; Vastrad C; Kotturshetti S
Sci Rep; 2022 Jun; 12(1):9157. PubMed ID: 35650387
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes related to the progression of type 1 diabetes by computational analysis.
Prashanth G; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
BMC Endocr Disord; 2021 Apr; 21(1):61. PubMed ID: 33827531
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Active Compound of Liu Wei Di Huang Wan for Treatment of Gestational Diabetes Mellitus via Network Pharmacology and Molecular Docking.
Xiong Y; Li Q; Chen X; Zhu T; Lu Q; Jiang G
J Diabetes Res; 2022; 2022():4808303. PubMed ID: 35669396
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential gene markers in gestational diabetes mellitus.
Tang W; Wang X; Chen L; Lu Y; Kang X
J Clin Lab Anal; 2022 Jul; 36(7):e24515. PubMed ID: 35718998
[TBL] [Abstract][Full Text] [Related]
17. Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis.
Ganekal P; Vastrad B; Vastrad C; Kotrashetti S
Ther Adv Cardiovasc Dis; 2023; 17():17539447231168471. PubMed ID: 37092838
[TBL] [Abstract][Full Text] [Related]
18. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis and its potential role in gestational diabetes mellitus: updated evidence from pathogenesis to therapy.
Zhao Y; Gao Q; Li B; Wang Y; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1177547. PubMed ID: 37664858
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics and Next-Generation Data Analysis for Identification of Genes and Molecular Pathways Involved in Subjects with Diabetes and Obesity.
Ganekal P; Vastrad B; Kavatagimath S; Vastrad C; Kotrashetti S
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837510
[No Abstract] [Full Text] [Related]
[Next] [New Search]
